Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: COCH) is a medical device company focused on implantable hearing technology, best known for its Acclaim Totally Implantable Active Middle Ear Implant. The company became publicly traded in 2023 through a business combination with Anzu Special Acquisition Corp I, a blank-check company sponsored by Anzu Partners. Operating in the hearing health segment of the broader medical device industry, Envoy Medical filed an 8-K current report with the SEC on August 27, 2026, under accession number 0001213900-26-094447. The company remains an active post-merger public entity subject to ongoing SEC reporting obligations. Sign up on SpacDesk for full filings history, sponsor data, and deep analytics on COCH and hundreds of other SPAC-originated companies.